Mounjaro vs Zepbound: Are They the Same Medication?

Same Molecule, Different Indications

Both Mounjaro and Zepbound are brand names for tirzepatide, a dual GIP/GLP-1 receptor agonist. They are manufactured by the same company. The difference is in their FDA-approved indications, not the active ingredient.

Mounjaro

Mounjaro is FDA-approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. It is not approved by the FDA specifically as a weight-loss medication.

Zepbound

Zepbound is FDA-approved for chronic weight management in adults who meet specific BMI criteria, alongside a reduced-calorie diet and increased physical activity.

What This Means for Patients

Insurance coverage, pricing, and prescribing decisions can vary significantly based on which brand and indication apply to a given patient. A licensed provider can help determine which option, if any, is appropriate. This is educational content and is not medical advice.

Looking for a more affordable path?

At RX Gleam, we offer compounded tirzepatide (the active ingredient in both Mounjaro and Zepbound) at a fraction of the brand-name price. Prescribed by a U.S.-licensed provider, compounded by a state-licensed pharmacy, and shipped to your door with free shipping. See our weight management treatments to learn more, or schedule a free pre-purchase consultation with our clinical team to talk through your options.